JP2019534695A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534695A5 JP2019534695A5 JP2019517246A JP2019517246A JP2019534695A5 JP 2019534695 A5 JP2019534695 A5 JP 2019534695A5 JP 2019517246 A JP2019517246 A JP 2019517246A JP 2019517246 A JP2019517246 A JP 2019517246A JP 2019534695 A5 JP2019534695 A5 JP 2019534695A5
- Authority
- JP
- Japan
- Prior art keywords
- casy
- polypeptide
- activity
- seq
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 58
- 229920001184 polypeptide Polymers 0.000 claims 56
- 102000004196 processed proteins & peptides Human genes 0.000 claims 56
- 230000000694 effects Effects 0.000 claims 38
- 210000004027 cell Anatomy 0.000 claims 34
- 108020004707 nucleic acids Proteins 0.000 claims 31
- 102000039446 nucleic acids Human genes 0.000 claims 31
- 150000007523 nucleic acids Chemical class 0.000 claims 31
- 125000003275 alpha amino acid group Chemical group 0.000 claims 26
- 108020005004 Guide RNA Proteins 0.000 claims 21
- 230000004927 fusion Effects 0.000 claims 14
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 12
- 239000002773 nucleotide Substances 0.000 claims 12
- 125000003729 nucleotide group Chemical group 0.000 claims 12
- 108020004414 DNA Proteins 0.000 claims 10
- 210000003527 eukaryotic cell Anatomy 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 108060004795 Methyltransferase Proteins 0.000 claims 3
- 230000002255 enzymatic effect Effects 0.000 claims 3
- 230000004048 modification Effects 0.000 claims 3
- 238000012986 modification Methods 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 3
- 239000004209 oxidized polyethylene wax Substances 0.000 claims 3
- 241000271566 Aves Species 0.000 claims 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims 2
- 241000238631 Hexapoda Species 0.000 claims 2
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 claims 2
- 241000270322 Lepidosauria Species 0.000 claims 2
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 claims 2
- 102000016397 Methyltransferase Human genes 0.000 claims 2
- 241000288906 Primates Species 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 210000003763 chloroplast Anatomy 0.000 claims 2
- 210000002308 embryonic cell Anatomy 0.000 claims 2
- 210000001163 endosome Anatomy 0.000 claims 2
- 230000002538 fungal effect Effects 0.000 claims 2
- 210000004602 germ cell Anatomy 0.000 claims 2
- 210000005260 human cell Anatomy 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000013518 transcription Methods 0.000 claims 2
- 230000035897 transcription Effects 0.000 claims 2
- 241000251468 Actinopterygii Species 0.000 claims 1
- 241000239290 Araneae Species 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 241000238421 Arthropoda Species 0.000 claims 1
- 230000005778 DNA damage Effects 0.000 claims 1
- 231100000277 DNA damage Toxicity 0.000 claims 1
- 230000033616 DNA repair Effects 0.000 claims 1
- 108010046331 Deoxyribodipyrimidine photo-lyase Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 108091006027 G proteins Proteins 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 108010033040 Histones Proteins 0.000 claims 1
- 102100034343 Integrase Human genes 0.000 claims 1
- 108010061833 Integrases Proteins 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- 102000003960 Ligases Human genes 0.000 claims 1
- 108090000364 Ligases Proteins 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 102100025169 Max-binding protein MNT Human genes 0.000 claims 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 108091093078 Pyrimidine dimer Proteins 0.000 claims 1
- 102000018120 Recombinases Human genes 0.000 claims 1
- 108010091086 Recombinases Proteins 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 108700019146 Transgenes Proteins 0.000 claims 1
- 102000008579 Transposases Human genes 0.000 claims 1
- 108010020764 Transposases Proteins 0.000 claims 1
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 claims 1
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 claims 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 102000005421 acetyltransferase Human genes 0.000 claims 1
- 108020002494 acetyltransferase Proteins 0.000 claims 1
- 230000006154 adenylylation Effects 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 230000022811 deglycosylation Effects 0.000 claims 1
- 230000006114 demyristoylation Effects 0.000 claims 1
- 230000027832 depurination Effects 0.000 claims 1
- 230000009504 deubiquitination Effects 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 230000007498 myristoylation Effects 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 claims 1
- 239000013635 pyrimidine dimer Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 108091006107 transcriptional repressors Proteins 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022202406A JP2023030067A (ja) | 2016-09-30 | 2022-12-19 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402849P | 2016-09-30 | 2016-09-30 | |
| US62/402,849 | 2016-09-30 | ||
| PCT/US2017/054047 WO2018064352A1 (en) | 2016-09-30 | 2017-09-28 | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022202406A Division JP2023030067A (ja) | 2016-09-30 | 2022-12-19 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019534695A JP2019534695A (ja) | 2019-12-05 |
| JP2019534695A5 true JP2019534695A5 (enExample) | 2020-11-12 |
| JP7306696B2 JP7306696B2 (ja) | 2023-07-11 |
Family
ID=61760117
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517246A Active JP7306696B2 (ja) | 2016-09-30 | 2017-09-28 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| JP2022202406A Pending JP2023030067A (ja) | 2016-09-30 | 2022-12-19 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022202406A Pending JP2023030067A (ja) | 2016-09-30 | 2022-12-19 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11371062B2 (enExample) |
| EP (1) | EP3532089A4 (enExample) |
| JP (2) | JP7306696B2 (enExample) |
| KR (2) | KR102812752B1 (enExample) |
| CN (1) | CN110418647B (enExample) |
| AU (1) | AU2017335883B2 (enExample) |
| BR (1) | BR112019006388A2 (enExample) |
| CA (1) | CA3038982A1 (enExample) |
| EA (1) | EA201990860A1 (enExample) |
| GB (1) | GB2569734B (enExample) |
| IL (1) | IL265599A (enExample) |
| MX (1) | MX2019003678A (enExample) |
| SA (1) | SA519401442B1 (enExample) |
| WO (1) | WO2018064352A1 (enExample) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
| AU2015298571B2 (en) | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| AU2015342749B2 (en) | 2014-11-07 | 2022-01-27 | Editas Medicine, Inc. | Methods for improving CRISPR/Cas-mediated genome-editing |
| EP3294896A1 (en) | 2015-05-11 | 2018-03-21 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
| WO2016201047A1 (en) | 2015-06-09 | 2016-12-15 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for improving transplantation |
| CA2999500A1 (en) | 2015-09-24 | 2017-03-30 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| US12043852B2 (en) | 2015-10-23 | 2024-07-23 | President And Fellows Of Harvard College | Evolved Cas9 proteins for gene editing |
| EP3433363A1 (en) | 2016-03-25 | 2019-01-30 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| EP4047092B1 (en) | 2016-04-13 | 2025-07-30 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
| US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
| KR20250103795A (ko) | 2016-08-03 | 2025-07-07 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| CN109804066A (zh) | 2016-08-09 | 2019-05-24 | 哈佛大学的校长及成员们 | 可编程cas9-重组酶融合蛋白及其用途 |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| JP7306696B2 (ja) | 2016-09-30 | 2023-07-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| CN110023494A (zh) | 2016-09-30 | 2019-07-16 | 加利福尼亚大学董事会 | Rna指导的核酸修饰酶及其使用方法 |
| AU2017342543B2 (en) | 2016-10-14 | 2024-06-27 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| US12286727B2 (en) | 2016-12-19 | 2025-04-29 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| EP3565907B1 (en) | 2017-01-06 | 2022-05-04 | Editas Medicine, Inc. | Methods of assessing nuclease cleavage |
| JP2020513783A (ja) * | 2017-01-18 | 2020-05-21 | エクシジョン バイオセラピューティクス インコーポレイテッド | Ｃｒｉｓｐｒ |
| US10995333B2 (en) * | 2017-02-06 | 2021-05-04 | 10X Genomics, Inc. | Systems and methods for nucleic acid preparation |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| EP3592381A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Cancer vaccine |
| KR20190127797A (ko) | 2017-03-10 | 2019-11-13 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 시토신에서 구아닌으로의 염기 편집제 |
| CA3057192A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| EP3615672A1 (en) | 2017-04-28 | 2020-03-04 | Editas Medicine, Inc. | Methods and systems for analyzing guide rna molecules |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| CN110997908A (zh) | 2017-06-09 | 2020-04-10 | 爱迪塔斯医药公司 | 工程化的cas9核酸酶 |
| EP3652312A1 (en) | 2017-07-14 | 2020-05-20 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
| CA3082251A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | Uses of adenosine base editors |
| BR112020008654A2 (pt) | 2017-11-01 | 2020-11-10 | The Regents Of The University Of California | composições casz e métodos de uso |
| WO2019089804A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Casy compositions and methods of use |
| WO2019089808A1 (en) * | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Class 2 crispr/cas compositions and methods of use |
| EP3724214A4 (en) | 2017-12-15 | 2021-09-01 | The Broad Institute Inc. | SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING |
| US11807877B1 (en) | 2018-03-22 | 2023-11-07 | National Technology & Engineering Solutions Of Sandia, Llc | CRISPR/Cas activity assays and compositions thereof |
| EP3796894A4 (en) * | 2018-04-24 | 2022-05-04 | Ligandal, Inc. | METHODS AND COMPOSITIONS FOR GENOMIC EDITING |
| CN112105728B (zh) * | 2018-05-07 | 2023-01-10 | 中国农业大学 | CRISPR/Cas效应蛋白及系统 |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| WO2019237032A1 (en) | 2018-06-07 | 2019-12-12 | Arc Bio, Llc | Compositions and methods for making guide nucleic acids |
| CA3104856A1 (en) | 2018-06-29 | 2020-01-02 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| WO2020023529A1 (en) * | 2018-07-24 | 2020-01-30 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| EP3830301B1 (en) | 2018-08-01 | 2024-05-22 | Mammoth Biosciences, Inc. | Programmable nuclease compositions and methods of use thereof |
| US12281338B2 (en) | 2018-10-29 | 2025-04-22 | The Broad Institute, Inc. | Nucleobase editors comprising GeoCas9 and uses thereof |
| WO2020142754A2 (en) * | 2019-01-04 | 2020-07-09 | Mammoth Biosciences, Inc. | Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection |
| JP7416451B2 (ja) * | 2019-01-14 | 2024-01-17 | ユニバーシティ オブ ロチェスター | ＣＲＩＳＰＲ－Ｃａｓによる標的化された核内ＲＮＡ切断及びポリアデニル化 |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| CN113811607A (zh) | 2019-03-07 | 2021-12-17 | 加利福尼亚大学董事会 | CRISPR-Cas效应子多肽和其使用方法 |
| DE112020001306T5 (de) | 2019-03-19 | 2022-01-27 | Massachusetts Institute Of Technology | Verfahren und zusammensetzungen zur editierung von nukleotidsequenzen |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| AU2020340353A1 (en) * | 2019-08-27 | 2022-03-24 | Arbor Biotechnologies, Inc. | Novel CRISPR DNA targeting enzymes and systems |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| AU2020412714A1 (en) * | 2019-12-23 | 2022-05-26 | The Regents Of The University Of California | CRISPR-Cas effector polypeptides and methods of use thereof |
| KR102651824B1 (ko) * | 2020-01-31 | 2024-03-27 | 현대모비스 주식회사 | 루프 에어백 장치 |
| KR102794727B1 (ko) * | 2020-03-31 | 2025-04-11 | 메타지노미, 인크. | 클래스 ii, 유형 ii crispr 시스템 |
| US20230332218A1 (en) * | 2020-04-21 | 2023-10-19 | Mammoth Biosciences, Inc. | Casy programmable nucleases and rna component systems |
| JP2023525304A (ja) | 2020-05-08 | 2023-06-15 | ザ ブロード インスティテュート，インコーポレーテッド | 標的二本鎖ヌクレオチド配列の両鎖同時編集のための方法および組成物 |
| WO2022140577A2 (en) | 2020-12-22 | 2022-06-30 | Chroma Medicine, Inc. | Compositions and methods for epigenetic editing |
| CN113151387B (zh) * | 2021-04-16 | 2022-08-16 | 安徽国肽生物科技有限公司 | 一种具有抗氧化和增强免疫功能的鳕鱼皮胶原蛋白肽及其制备方法 |
| US20240102007A1 (en) | 2021-06-01 | 2024-03-28 | Arbor Biotechnologies, Inc. | Gene editing systems comprising a crispr nuclease and uses thereof |
| WO2023283622A1 (en) | 2021-07-08 | 2023-01-12 | Montana State University | Crispr-based programmable rna editing |
| EP4373963A4 (en) | 2021-07-21 | 2025-06-18 | Montana State University | NUCLEIC ACID DETECTION USING A TYPE III CRISPR COMPLEX |
| WO2023028348A1 (en) | 2021-08-27 | 2023-03-02 | Metagenomi, Inc. | Enzymes with ruvc domains |
| EP4437096A4 (en) | 2021-11-24 | 2025-09-24 | Metagenomi Inc | ENDONUCLEASE SYSTEMS |
| CN114921439B (zh) * | 2022-06-16 | 2024-04-26 | 尧唐(上海)生物科技有限公司 | CRISPR-Cas效应子蛋白、其基因编辑系统及应用 |
| US12435357B2 (en) | 2022-12-22 | 2025-10-07 | Kanso Diagnostics Ltd. | Diagnostic device for detecting a target nucleic acid molecule in a biological sample |
| AU2024220323A1 (en) | 2023-02-15 | 2025-08-14 | Arbor Biotechnologies, Inc. | Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript |
| AU2024270764A1 (en) | 2023-05-15 | 2025-12-04 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2025049527A1 (en) * | 2023-08-29 | 2025-03-06 | The Medical College Of Wisconsin, Inc. | Y-rna compositions and methods of using the same |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004521606A (ja) | 2000-05-24 | 2004-07-22 | サード・ウェーブ・テクノロジーズ・インク | Ｒｎａの検出法 |
| US6773885B1 (en) | 2000-09-29 | 2004-08-10 | Integrated Dna Technologies, Inc. | Compositions and methods for visual ribonuclease detection assays |
| CN1886512A (zh) | 2002-04-23 | 2006-12-27 | 斯克里普斯研究所 | 多肽在叶绿体中的表达以及用于表达多肽的组合物和方法 |
| EP1580273A1 (en) | 2004-03-26 | 2005-09-28 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Peptide-based method for monitoring gene expression in a host cell |
| CN101283089A (zh) | 2005-10-07 | 2008-10-08 | 加利福尼亚大学董事会 | 修饰细胞色素p450酶的编码核酸和其应用方法 |
| US9689031B2 (en) | 2007-07-14 | 2017-06-27 | Ionian Technologies, Inc. | Nicking and extension amplification reaction for the exponential amplification of nucleic acids |
| EP2432794B1 (en) | 2009-05-22 | 2017-08-30 | The Research Foundation of State University of New York | Trans-acting rna switches |
| EP2536846B1 (en) | 2010-02-15 | 2016-10-05 | Cascade Biosystems, Inc. | Methods and materials for detecting viral or microbial infections |
| US20130261196A1 (en) | 2010-06-11 | 2013-10-03 | Lisa Diamond | Nucleic Acids For Multiplex Organism Detection and Methods Of Use And Making The Same |
| US9730967B2 (en) | 2011-02-04 | 2017-08-15 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
| US8815782B2 (en) | 2011-11-11 | 2014-08-26 | Agilent Technologies, Inc. | Use of DNAzymes for analysis of an RNA sample |
| FI3597749T3 (fi) | 2012-05-25 | 2023-10-09 | Univ California | Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten |
| US20140024024A1 (en) | 2012-07-17 | 2014-01-23 | General Electric Company | Methods of detecting dna, rna and protein in biological samples |
| KR101656236B1 (ko) | 2012-10-23 | 2016-09-12 | 주식회사 툴젠 | 표적 DNA에 특이적인 가이드 RNA 및 Cas 단백질을 암호화하는 핵산 또는 Cas 단백질을 포함하는, 표적 DNA를 절단하기 위한 조성물 및 이의 용도 |
| PT3363902T (pt) | 2012-12-06 | 2019-12-19 | Sigma Aldrich Co Llc | Modificação e regulação de genoma baseadas em crispr |
| KR20150105956A (ko) | 2012-12-12 | 2015-09-18 | 더 브로드 인스티튜트, 인코퍼레이티드 | 서열 조작 및 치료적 적용을 위한 시스템, 방법 및 조성물의 전달, 유전자 조작 및 최적화 |
| EP4234696A3 (en) | 2012-12-12 | 2023-09-06 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
| CN103088128B (zh) | 2013-01-09 | 2015-11-18 | 华中科技大学 | 一种microRNA的二次循环扩增检测方法及试剂盒 |
| AU2014235794A1 (en) | 2013-03-14 | 2015-10-22 | Caribou Biosciences, Inc. | Compositions and methods of nucleic acid-targeting nucleic acids |
| US9234213B2 (en) | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| US20160298096A1 (en) | 2013-11-18 | 2016-10-13 | Crispr Therapeutics Ag | Crispr-cas system materials and methods |
| EP3080266B1 (en) * | 2013-12-12 | 2021-02-03 | The Regents of The University of California | Methods and compositions for modifying a single stranded target nucleic acid |
| EP3080271B1 (en) | 2013-12-12 | 2020-02-12 | The Broad Institute, Inc. | Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems |
| US9850525B2 (en) | 2014-01-29 | 2017-12-26 | Agilent Technologies, Inc. | CAS9-based isothermal method of detection of specific DNA sequence |
| EP3126498A4 (en) | 2014-03-20 | 2017-08-23 | Université Laval | Crispr-based methods and products for increasing frataxin levels and uses thereof |
| WO2015157534A1 (en) | 2014-04-10 | 2015-10-15 | The Regents Of The University Of California | Methods and compositions for using argonaute to modify a single stranded target nucleic acid |
| WO2015191693A2 (en) | 2014-06-10 | 2015-12-17 | Massachusetts Institute Of Technology | Method for gene editing |
| CA2958292A1 (en) | 2014-08-19 | 2016-02-25 | President And Fellows Of Harvard College | Rna-guided systems for probing and mapping of nucleic acids |
| WO2016094872A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Dead guides for crispr transcription factors |
| EP3889260A1 (en) | 2014-12-12 | 2021-10-06 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
| WO2016106236A1 (en) | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
| WO2016123243A1 (en) | 2015-01-28 | 2016-08-04 | The Regents Of The University Of California | Methods and compositions for labeling a single-stranded target nucleic acid |
| GB201506509D0 (en) | 2015-04-16 | 2015-06-03 | Univ Wageningen | Nuclease-mediated genome editing |
| CN109536474A (zh) | 2015-06-18 | 2019-03-29 | 布罗德研究所有限公司 | 降低脱靶效应的crispr酶突变 |
| AU2016279062A1 (en) | 2015-06-18 | 2019-03-28 | Omar O. Abudayyeh | Novel CRISPR enzymes and systems |
| CA3012631A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| US9580727B1 (en) | 2015-08-07 | 2017-02-28 | Caribou Biosciences, Inc. | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides |
| KR102761827B1 (ko) | 2015-10-22 | 2025-02-03 | 더 브로드 인스티튜트, 인코퍼레이티드 | 타입 vi-b crispr 효소 및 시스템 |
| EP3400299B1 (en) | 2016-01-08 | 2020-11-11 | University of Georgia Research Foundation, Inc. | Methods for cleaving dna and rna molecules |
| US11441146B2 (en) | 2016-01-11 | 2022-09-13 | Christiana Care Health Services, Inc. | Compositions and methods for improving homogeneity of DNA generated using a CRISPR/Cas9 cleavage system |
| US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| CA3015360A1 (en) | 2016-02-23 | 2017-08-31 | Arc Bio, Llc | Methods and compositions for target detection |
| WO2017176529A1 (en) | 2016-04-06 | 2017-10-12 | Temple Univesity-Of The Commonwealth System Of Higher Education | Compositions for eradicating flavivirus infections in subjects |
| US11371081B2 (en) | 2016-05-25 | 2022-06-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Portable, low-cost pathogen detection and strain identification platform |
| WO2017207589A1 (en) | 2016-06-01 | 2017-12-07 | Kws Saat Se | Hybrid nucleic acid sequences for genome engineering |
| US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
| JP7267013B2 (ja) | 2016-06-17 | 2023-05-01 | ザ・ブロード・インスティテュート・インコーポレイテッド | Ｖｉ型ｃｒｉｓｐｒオルソログ及び系 |
| DK3474669T3 (da) | 2016-06-24 | 2022-06-27 | Univ Colorado Regents | Fremgangsmåde til generering af stregkodede kombinatoriske biblioteker |
| KR20250103795A (ko) | 2016-08-03 | 2025-07-07 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| US12431216B2 (en) | 2016-08-17 | 2025-09-30 | Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
| JP7306696B2 (ja) | 2016-09-30 | 2023-07-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| CN110023494A (zh) | 2016-09-30 | 2019-07-16 | 加利福尼亚大学董事会 | Rna指导的核酸修饰酶及其使用方法 |
| CN106701830B (zh) | 2016-12-07 | 2020-01-03 | 湖南人文科技学院 | 一种敲除猪胚胎p66shc基因的方法 |
| JP7228514B2 (ja) | 2016-12-09 | 2023-02-24 | ザ・ブロード・インスティテュート・インコーポレイテッド | Ｃｒｉｓｐｒエフェクターシステムベースの診断法 |
| JP2020513783A (ja) | 2017-01-18 | 2020-05-21 | エクシジョン バイオセラピューティクス インコーポレイテッド | Ｃｒｉｓｐｒ |
| CN106548744B (zh) | 2017-01-20 | 2019-11-01 | 京东方科技集团股份有限公司 | 栅极驱动单元及其驱动方法、栅极驱动电路和显示装置 |
| WO2018152418A1 (en) | 2017-02-17 | 2018-08-23 | Temple University - Of The Commonwealth System Of Higher Education | Gene editing therapy for hiv infection via dual targeting of hiv genome and ccr5 |
| US11739335B2 (en) | 2017-03-24 | 2023-08-29 | CureVac SE | Nucleic acids encoding CRISPR-associated proteins and uses thereof |
| EP3612551B1 (en) | 2017-04-21 | 2024-09-04 | The General Hospital Corporation | Variants of cpf1 (cas12a) with altered pam specificity |
| US20200407737A1 (en) | 2017-05-03 | 2020-12-31 | KWS SAAT SE & Co. KGaA | Use of crispr-cas endonucleases for plant genome engineering |
| EP3665279B1 (en) | 2017-08-09 | 2023-07-19 | Benson Hill, Inc. | Compositions and methods for modifying genomes |
| US20200115688A1 (en) | 2017-08-15 | 2020-04-16 | The Regents Of The University Of California | Compositions and methods for enhancing genome editing |
| US20200339967A1 (en) | 2017-11-01 | 2020-10-29 | The Regents Of The University Of California | Cas12c compositions and methods of use |
| WO2019089804A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Casy compositions and methods of use |
| BR112020008654A2 (pt) | 2017-11-01 | 2020-11-10 | The Regents Of The University Of California | composições casz e métodos de uso |
| WO2019089808A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Class 2 crispr/cas compositions and methods of use |
| US10253365B1 (en) | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
| US20190185933A1 (en) | 2017-12-20 | 2019-06-20 | William Marsh Rice University | Detection and quantification of rare variants with low-depth sequencing via selective allele enrichment or depletion |
| US20210108267A1 (en) | 2017-12-22 | 2021-04-15 | The Broad Institute, Inc. | Crispr effector system based multiplex diagnostics |
| US20210198664A1 (en) | 2018-05-16 | 2021-07-01 | Arbor Biotechnologies, Inc. | Novel crispr-associated systems and components |
| WO2020023529A1 (en) | 2018-07-24 | 2020-01-30 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| EP3841205A4 (en) | 2018-08-22 | 2022-08-17 | The Regents of The University of California | Variant type v crispr/cas effector polypeptides and methods of use thereof |
| US12435321B2 (en) | 2018-11-15 | 2025-10-07 | China Agricultural University | CRISPR/Cas12J enzyme and system |
| CN110713940B (zh) | 2019-10-15 | 2021-02-19 | 天津科技大学 | 一种高产重油出芽短梗霉菌株及其构建方法与用途 |
| EP4211240A4 (en) | 2020-09-09 | 2025-01-08 | The Regents of the University of California | CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF |
-
2017
- 2017-09-28 JP JP2019517246A patent/JP7306696B2/ja active Active
- 2017-09-28 EP EP17857432.3A patent/EP3532089A4/en active Pending
- 2017-09-28 KR KR1020237041560A patent/KR102812752B1/ko active Active
- 2017-09-28 MX MX2019003678A patent/MX2019003678A/es unknown
- 2017-09-28 US US16/335,630 patent/US11371062B2/en active Active
- 2017-09-28 KR KR1020197012246A patent/KR20190072548A/ko not_active Ceased
- 2017-09-28 EA EA201990860A patent/EA201990860A1/ru unknown
- 2017-09-28 GB GB1905581.3A patent/GB2569734B/en active Active
- 2017-09-28 WO PCT/US2017/054047 patent/WO2018064352A1/en not_active Ceased
- 2017-09-28 AU AU2017335883A patent/AU2017335883B2/en active Active
- 2017-09-28 CN CN201780074122.7A patent/CN110418647B/zh active Active
- 2017-09-28 BR BR112019006388A patent/BR112019006388A2/pt unknown
- 2017-09-28 CA CA3038982A patent/CA3038982A1/en active Pending
-
2019
- 2019-03-25 IL IL265599A patent/IL265599A/en unknown
- 2019-03-28 SA SA519401442A patent/SA519401442B1/ar unknown
-
2022
- 2022-05-19 US US17/749,017 patent/US12258575B2/en active Active
- 2022-12-19 JP JP2022202406A patent/JP2023030067A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019534695A5 (enExample) | ||
| JP2019532644A5 (enExample) | ||
| JP7478772B2 (ja) | Ｃｒｉｓｐｒに基づくゲノム修飾および制御 | |
| JP7095066B2 (ja) | 単一ステップの複数標的化を通じた標的化された遺伝子修飾のための方法及び組成物 | |
| JP6688231B2 (ja) | 標的遺伝子座を修飾するための方法及び組成物 | |
| US20180049412A1 (en) | Dna knock-in system | |
| US20240336905A1 (en) | Class ii, type v crispr systems | |
| CN113652445A (zh) | 基因组编辑系统和方法 | |
| Grabher et al. | Recent advances in meganuclease-and transposon-mediated transgenesis of medaka and zebrafish | |
| HK1218389B (zh) | 基於crispr的基因组修饰和调控 |